1040 - Growing Demand for Menopausal Hormone Therapies Brings Excitement—and New Concerns
Public Health On Call
The Johns Hopkins Bloomberg School of Public Health
4.6 • 644 Ratings
🗓️ 22 April 2026
⏱️ 19 minutes
🧾️ Download transcript
Summary
About this episode:
Following the FDA's removal of black box warnings for hormone therapy drugs, demand has skyrocketed for menopause treatments. In this episode: why this explosion in popularity marks a trend in the right direction for quality reproductive care while also raising concerns about "menowashed" products and blanket prescribing of hormonal interventions.
Guests:
Dr. Wendy L. Bennett, MPH, is a primary care doctor and associate professor with appointments at the Johns Hopkins Bloomberg School of Public Health and School of Medicine.
Dr. Tina Zhang is a primary care doctor and assistant professor at the Johns Hopkins University School of Medicine.
Host:
Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs.
Show links and related content:
-
Why the 'mad scramble' to fill hormone therapy prescriptions for menopause—NPR
-
FACT SHEET: FDA Initiates Removal of "Black Box" Warnings from Menopausal Hormone Replacement Therapy Products—U.S. Department of Health and Human Services
-
What Is a Black Box Warning?—Johns Hopkins Bloomberg School of Public Health
-
De-medicalizing Menopause—Public Health On Call (March 2024)
Transcript information:
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel.
Contact us:
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:
-
Here's our RSS feed
Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Public Health On Call, a podcast from the Johns Hopkins Bloomberg School of Public Health, |
| 0:05.9 | where we bring evidence, experience, and perspective to make sense of today's leading health challenges. |
| 0:16.3 | If you have questions or ideas for us, please send an email to public health question at jhhhu.edu. |
| 0:23.8 | That's public health question at jhhu.edu for future podcast episodes. |
| 0:31.5 | It's Lindsay Smith Rogers. Today, menopause, a universal life stage that has often been overlooked in health care despite its broad impacts on women's health. |
| 0:41.4 | Stephanie Desmond talks to two Johns Hopkins primary care doctors, Tina Zang and Wendy Bennett, about our evolving understanding of menopause care and hormone therapy, as well as emerging challenges from social media influencers and menow washing, |
| 0:55.7 | where unproven products are marketed as treatments and can be misleading. |
| 1:00.9 | Let's listen. |
| 1:02.1 | Wendy Bennett and Tina Zhang, thanks so much for joining me. |
| 1:05.2 | Thank you so much for having us. |
| 1:06.8 | We're so excited to be here. |
| 1:08.8 | Thank you. |
| 1:10.2 | Sometimes menopause is framed as this silent topic, but I got to tell you, in my circle of friends, |
| 1:16.5 | it's all we talk about all the time. |
| 1:18.6 | But when it comes to the health care system, research, public health, it's still surprisingly |
| 1:23.5 | overlooked. |
| 1:24.9 | Tina, why is that? |
| 1:26.2 | Yeah, that's a great question, Stephanie. I think menopause has been kind of overlooked. Tina, why is that? Yeah, that's a great question, Stephanie. I think menopause has |
| 1:29.5 | been kind of overlooked in medical education and clinical care for the longest time. And there are a |
| 1:38.4 | couple of reasons behind it. But I think one of the biggest drivers is because some research in the past made it seem like hormone |
| 1:46.1 | therapy had more risks than benefits. A whole generation of women were recommended to not |
| 1:51.8 | take hormone therapy. And as a result, they just thought maybe we should just not talk about it. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Johns Hopkins Bloomberg School of Public Health, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Johns Hopkins Bloomberg School of Public Health and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

